News Daily News No Uptick in CVD Events After COVID-19 Vaccination in Older Adults Michael O'Riordan November 29, 2021
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
News Daily News Women Stand to Gain the Most From Standardized STEMI Protocols Michael O'Riordan September 30, 2021
News Conference News ESC 2021 OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT Shelley Wood September 02, 2021
News Conference News ESC 2021 MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk Shelley Wood August 28, 2021
News Daily News OMT Boosts Survival in Revascularized Patients at 10 Years Michael O'Riordan June 29, 2021
News Daily News Statins Not Linked to Dementia or Memory Changes: ASPREE Michael O'Riordan June 21, 2021
News Daily News Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors Michael O'Riordan June 16, 2021
News Daily News In Female Veterans With Early ASCVD, Secondary Prevention Falls Short Michael O'Riordan April 21, 2021
News Daily News Observational Study Supports Continuing Oral Anticoagulation During PCI Michael O'Riordan April 06, 2021
News Daily News Primary PCI Underused but Just as Effective in Cancer Patients With STEMI Michael O'Riordan February 04, 2021
News Daily News Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy Caitlin E. Cox November 03, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Daily News Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement Yael L. Maxwell August 06, 2020
News Conference News ACC 2020 TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients Todd Neale March 31, 2020
News Daily News Outcome Differences Between Men and Women With PAD: EUCLID Insights L.A. McKeown February 11, 2020
News Daily News For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality Michael O'Riordan December 05, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019